Tighe Reardon, Acting Chief Financial Officer at Janux Therapeutics, Inc. (JANX), bought 1,699,708 shares at $5.87 ($10.0M) on 2023-11-13, disclosed to the SEC on 2023-11-15.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.87 | 849,854 | $5.0M | 50.0% |
| 2 | $5.87 | 849,854 | $5.0M | 50.0% |
| Total | $5.87 avg | 1,699,708 | $10.0M | 100% |
| Filing → |
| THOR | BUY | 2018-12-13 | $6.0M | — | Filing → |